Scientific & Medical Advisors
Dr. Sonis is a world-renowned expert in epithelial injury associated with cancer therapy. His development of predictive animal models has enabled the investigation of the biological basis of mucositis and has assisted in the development of potential therapies. The results of his studies on the molecular and cellular pathogenesis of mucositis have established the basis of the mechanistic paradigm for mucosal injury. Dr. Sonis’ interest in the genomic basis for toxicity risk and its pathology has led to innovative genomics-based analytical approaches to clinically actionable outcomes to personalize disease therapy. Dr. Sonis has published extensively on the clinical, biological, and health economic aspects of cancer and complications associated with its treatment. He is the author of over 200 original publications, reviews and chapters, 9 books, and 5 patents. Dr. Sonis has obtained degrees from Tufts University and Harvard University and completed his post-doctoral education (tumor immunology) at Oxford University. He holds appointments at the Harvard School of Dental Medicine (Clinical Professor of Oral Medicine, Department of Oral Medicine, Infection and Immunity), the Dana-Farber Cancer Institute and Brigham and Women’s Hospital where he is Division Chief and Senior Surgeon.
Dr. LaCouture is the program director at Memorial Sloane Kettering. Dr. LaCouture is a board-certified dermatologist with special interest in the dermatologic side effects of cancer treatments. His clinical focus is the recognition and management of the side effects and conditions of the skin, hair, and nails that may arise in cancer patients and survivors as a consequence of chemotherapy, radiation, or transplantation. His research focuses on exploring new skin treatments that do not interfere with the effectiveness of anticancer drugs. Dr. Lacouture received his MD degree in 1997 from Javeriana University, in Colombia. He completed residencies at Cleveland Clinic Foundation and the University of Chicago Hospital, and a fellowship at Brigham and Women’s Hospital. Prior to joining Memorial Sloan Kettering, he was on the attending staff at Northwestern University’s Feinberg School of Medicine.
Dr. Treister is the chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute. He is the program director for the Harvard School of Dental Medicine/BWH residency program in oral medicine. Under Dr. Treister’s leadership, this program has achieved national recognition. Dr. Treister also serves as an associate surgeon at Dana-Farber/Brigham and Women’s Cancer Center and is a consulting staff member of Boston Children’s Hospital. He is an assistant professor at Harvard School of Dental Medicine. Dr. Treister earned his dental degree from the University of Pennsylvania School of Dental Medicine. He completed an oral medicine residency at Harvard School of Dental Medicine/BWH and is board certified in oral medicine.